Skip to main content
. 2022 Jan 20;148(3):268–276. doi: 10.1001/jamaoto.2021.4052

Table. Primary Tumor Response vs Newly FDG-Avid Ipsilateral Lymph Nodes.

Newly FDG-avid ipsilateral lymph nodes at T1 Primary tumor response, No. (%)
<10% ≥10% Effect size,a % (90% CI) <50% ≥50% Effect size,a % (90% CI)
Yes (n = 13) 5 (38.5) 8 (61.5) –2.7 (–33.3 to 27.9) 9 (69.2) 4 (30.8) 16.5 (–9.6 to 42.6)
No (n = 14) 5 (35.7) 9 (64.3) 12 (85.7) 2 (14.3)
a

Estimates the difference in percentages of responders for Yes or No.